MarketPeel
Insider Trading Intelligence
Pricing
…
RH

Richard A. Heyman

ELVN
DIRECTOR · ENLIVEN THERAPEUTICS, INC. · CIK 0001584759
FILING MIX · LIFETIME31%/69%
BUYS
29
SELLS
64
TOTAL VALUE
$2.59M
COMPANIES
3
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
269,219
AVG SELL PX
$23.07
TRADE KIND
SHOWING 93 / 93
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
57 backtested trades · 8 horizons · 35 pending
Forward-return performance of every backtestable P/S trade by Richard A. Heyman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d57+52.63%-0.55%-0.05%-0.50%-0.20%-0.45
14d57+54.39%-1.45%+0.04%-1.48%-0.17%-0.95
30d57+56.14%-4.33%+1.27%-5.61%-2.88%-2.53
60d57+45.61%+2.05%+3.69%-1.65%+2.60%-0.55
90d57+56.14%+3.54%+6.11%-2.57%-12.94%-0.56
180d57(8 pending)+67.35%-9.33%+8.44%-17.78%-28.81%-3.40
1y57(8 pending)+77.55%-30.30%+8.30%-38.60%-44.54%-6.27
2y57(19 pending)+57.89%-18.69%+19.43%-38.12%-69.26%-4.17
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ELVN · 22,647 shares · as of Feb 17, 2026
037,45574,910112,365149,820202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 29 buys / 64 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,230$26.18$32.2K22,647Feb 17, 2026Feb 19, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,234——19,234Feb 12, 2026Feb 17, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
512$26.46$13.5K24,595Jan 20, 2026Jan 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
718$26.96$19.4K23,877Jan 20, 2026Jan 22, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,500$12.00$42.0K41,800Jan 16, 2026Jan 20, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,200$12.00$38.4K213,072Jan 16, 2026Jan 20, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,285$25.00$107.1K25,107Jan 9, 2026Jan 12, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,015$25.04$200.7K29,392Jan 8, 2026Jan 12, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,620$25.00$40.5K25,545Jan 8, 2026Jan 12, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jan 2, 2026Jan 6, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
1,447$3.75$5.4K45,300Oct 3, 2025Oct 3, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
13,228——33,700Oct 3, 2025Oct 3, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
31,353$1.60$50.2K43,853Oct 3, 2025Oct 3, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
18,125——0Oct 3, 2025Oct 3, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
1,447——52,253Oct 3, 2025Oct 3, 2025 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,500——33,500Jun 5, 2025Jun 9, 2025 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,014——23,014Feb 6, 2025Feb 10, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Jan 2, 2025Jan 6, 2025 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
817$30.00$24.5K123,673Oct 18, 2024Oct 22, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
753$30.00$22.6K27,165Oct 18, 2024Oct 22, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$27.67$35.1K124,490Oct 15, 2024Oct 17, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,825$27.51$77.7K125,760Oct 4, 2024Oct 8, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
518$27.54$14.3K128,585Oct 1, 2024Oct 3, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$22.41$28.5K129,103Sep 16, 2024Sep 18, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
620$23.70$14.7K130,373Aug 15, 2024Aug 19, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
650$22.82$14.8K130,993Aug 15, 2024Aug 19, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
649$27.50$17.8K27,918Jul 31, 2024Aug 2, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,702$27.51$46.8K131,643Jul 31, 2024Aug 2, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$24.80$31.5K133,345Jul 15, 2024Jul 17, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$21.48$27.3K134,615Jun 17, 2024Jun 20, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,600——25,600Jun 12, 2024Jun 14, 2024 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
67,500——67,500Jun 6, 2024Jun 10, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$23.74$30.1K135,885May 16, 2024May 20, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
80$20.68$1.7K137,155Apr 15, 2024Apr 15, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,190$19.94$23.7K137,235Apr 15, 2024Apr 15, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
649$25.00$16.2K28,567Apr 11, 2024Apr 15, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,045$25.03$126.3K138.425Apr 11, 2024Apr 15, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$14.50$18.4K143,470Mar 19, 2024Mar 21, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$17.42$22.1K144,740Feb 15, 2024Feb 20, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,043——21,043Feb 13, 2024Feb 15, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
29,205——29,205Feb 13, 2024Feb 20, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,270$16.41$20.8K146,010Jan 30, 2024Feb 1, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
168$13.00$2.2K147,280Dec 22, 2023Dec 26, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
35$13.00$45529,216Dec 22, 2023Dec 26, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7$13.00$91147,448Dec 21, 2023Dec 26, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6$13.00$7829,251Dec 21, 2023Dec 26, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,915$13.02$24.9K29,257Dec 20, 2023Dec 21, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,110$13.02$27.5K147,455Dec 20, 2023Dec 21, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
255$13.00$3.3K149,565Dec 19, 2023Dec 21, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,500——20,500Jun 14, 2023Jun 15, 2023 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
21,500——21,500Jun 8, 2023Jun 12, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,172——31,172Feb 23, 2023Feb 27, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,657——20,657Feb 23, 2023Feb 27, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
149,820——149,820Feb 23, 2023Feb 27, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
37,407——37,407Feb 23, 2023Feb 27, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
34,458——34,458Feb 23, 2023Apr 6, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
53,700——53,700Jun 17, 2022Jun 17, 2022 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,500——19,500Jun 2, 2022Jun 6, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
682$25.03$17.1K216,272Sep 15, 2021Sep 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
706$25.05$17.7K216,954Sep 14, 2021Sep 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
601$25.01$15.0K217,660Sep 13, 2021Sep 14, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
479$25.10$12.0K218,261Sep 10, 2021Sep 14, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
1,086$25.11$27.3K218,740Sep 7, 2021Sep 9, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,625——16,625Jun 16, 2021Jun 17, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,333——16,333Jun 2, 2021Jun 9, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
764$32.15$24.6K211Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
553$33.61$18.6K5Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
975$975.00$950.6K975Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,950——15,901Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
230$33.75$7.8K2Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
975——7,951Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
975$2.95$2.9K975Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
743$32.16$23.9K232Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,950$2.95$5.8K1,950Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,392$32.15$44.8K558Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
2$34.67$690Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
5$34.67$1730Jun 1, 2021Jun 2, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
209$33.79$7.1K2Jun 1, 2021Jun 2, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
100$25.00$2.5K219,826May 24, 2021May 24, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
600$25.25$15.2K219,926May 21, 2021May 24, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
700$25.08$17.6K220,526May 20, 2021May 24, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
2,161$25.32$54.7K221,226May 18, 2021May 18, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
498$25.07$12.5K223,387May 17, 2021May 18, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
3,215$25.31$81.4K223,885May 14, 2021May 18, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,781——5,781May 12, 2021Jul 23, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
100$25.11$2.5K227,100May 11, 2021May 13, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
100$25.26$2.5K227,200Apr 30, 2021Apr 30, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
100$25.08$2.5K227,300Apr 28, 2021Apr 30, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
100$25.00$2.5K227,400Apr 1, 2021Apr 5, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
45,332——45,332Nov 11, 2020Nov 12, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
62,500——0Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
62,500——227,500Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,625——16,625Apr 23, 2020Apr 27, 2020 ↗View →
Other insiders · ELVN
Loading peer insiders…
About this filer
CIK 0001584759
ROLE
Director
PRIMARY
ELVN
COMPANIES
3
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001584759DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback